123 related articles for article (PubMed ID: 37551612)
21. Prognostic impact of colorectal cancer patients with bone metastases: a single-center experience.
Li T; Jing H; Zhang Y; Cao Z; Zhao L; Zhang X; Sun T; Zhang M
Updates Surg; 2023 Dec; 75(8):2245-2256. PubMed ID: 37976001
[TBL] [Abstract][Full Text] [Related]
22. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.
Cascinu S; Poli D; Zaniboni A; Lonardi S; Labianca R; Sobrero A; Rosati G; Di Bartolomeo M; Scartozzi M; Zagonel V; Pella N; Banzi M; Torri V
Eur J Cancer; 2019 Apr; 111():1-7. PubMed ID: 30797014
[TBL] [Abstract][Full Text] [Related]
23. Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III Study.
Chibaudel B; André T; Tournigand C; Louvet C; Benetkiewicz M; Larsen AK; de Gramont A
Clin Colorectal Cancer; 2020 Sep; 19(3):200-208.e1. PubMed ID: 32303437
[TBL] [Abstract][Full Text] [Related]
24. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and molecular differences in colorectal cancer according to location.
Hsu YL; Lin CC; Jiang JK; Lin HH; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Lin JK; Lin PC; Chang SC
Int J Biol Markers; 2019 Mar; 34(1):47-53. PubMed ID: 30854932
[TBL] [Abstract][Full Text] [Related]
26. Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies.
Boeckx N; Koukakis R; Op de Beeck K; Rolfo C; Van Camp G; Siena S; Tabernero J; Douillard JY; André T; Peeters M
Clin Colorectal Cancer; 2018 Sep; 17(3):170-178.e3. PubMed ID: 29627309
[TBL] [Abstract][Full Text] [Related]
27. The Prognosis and Recurrence Pattern of Right- and Left-Sided Colon Cancer in Stage II, Stage III, and Liver Metastasis After Curative Resection.
Nakamura Y; Hokuto D; Koyama F; Matsuo Y; Nomi T; Yoshikawa T; Kamitani N; Sadamitsu T; Takei T; Matsumoto Y; Iwasa Y; Fukuoka K; Obara S; Nakamoto T; Kuge H; Sho M
Ann Coloproctol; 2021 Oct; 37(5):326-336. PubMed ID: 32972100
[TBL] [Abstract][Full Text] [Related]
28. Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?
Liu F; Li C; Jia H; Yang L; Wu Y; Zhao J; Cai S; Zhu J; Xu Y
Oncotarget; 2017 Jun; 8(24):38682-38692. PubMed ID: 28418874
[TBL] [Abstract][Full Text] [Related]
29. Primary tumor location as a prognostic factor in metastatic colorectal cancer.
Loupakis F; Yang D; Yau L; Feng S; Cremolini C; Zhang W; Maus MK; Antoniotti C; Langer C; Scherer SJ; Müller T; Hurwitz HI; Saltz L; Falcone A; Lenz HJ
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25713148
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers.
Ozawa T; Hashiguchi Y; Yagi T; Fukushima Y; Shimada R; Hayama T; Tsuchiya T; Nozawa K; Iinuma H; Ishihara S; Matsuda K
Int J Colorectal Dis; 2019 Oct; 34(10):1731-1739. PubMed ID: 31478086
[TBL] [Abstract][Full Text] [Related]
31. Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.
Lee MM; MacKinlay A; Semira C; Schieber C; Jimeno Yepes AJ; Lee B; Wong R; Hettiarachchige CKH; Gunn N; Tie J; Wong HL; Skinner I; Jones IT; Keck J; Kosmider S; Tran B; Field K; Gibbs P
Clin Colorectal Cancer; 2018 Sep; 17(3):e569-e577. PubMed ID: 29980491
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis.
Gholamalizadeh H; Zafari N; Velayati M; Fiuji H; Maftooh M; Ghorbani E; Hassanian SM; Khazaei M; Ferns GA; Nazari E; Avan A
Clin Exp Med; 2023 Dec; 23(8):4369-4383. PubMed ID: 37405571
[TBL] [Abstract][Full Text] [Related]
33. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
[TBL] [Abstract][Full Text] [Related]
34. Metastatic spread pattern after curative colorectal cancer surgery. A retrospective, longitudinal analysis.
Augestad KM; Bakaki PM; Rose J; Crawshaw BP; Lindsetmo RO; Dørum LM; Koroukian SM; Delaney CP
Cancer Epidemiol; 2015 Oct; 39(5):734-44. PubMed ID: 26277328
[TBL] [Abstract][Full Text] [Related]
35. The prognostic implications of primary tumor location on recurrence in early-stage colorectal cancer with no associated risk factors.
Kang SI; Kim DW; Kwak Y; Lee HS; Kim MH; Kim MJ; Oh HK; Kang SB
Int J Colorectal Dis; 2018 Jun; 33(6):719-726. PubMed ID: 29594445
[TBL] [Abstract][Full Text] [Related]
36. Real-world Data for High-risk Stage II Colorectal Cancer - The Role of Tumor Side in the Adjuvant Setting.
Araujo CS; Venchiarutti Moniz CM; Bonadio RC; Watarai GY; Rojas J; Nogueira PVS; Martinez JK; Moraes PMG; Braghiroli MI; Sabbaga J; Hoff PM
Clin Colorectal Cancer; 2021 Jun; 20(2):e100-e108. PubMed ID: 33234431
[TBL] [Abstract][Full Text] [Related]
37. Left-sided location is a risk factor for lymph node metastasis of T1 colorectal cancer: a single-center retrospective study.
Mochizuki K; Kudo SE; Ichimasa K; Kouyama Y; Matsudaira S; Takashina Y; Maeda Y; Ishigaki T; Nakamura H; Toyoshima N; Mori Y; Misawa M; Ogata N; Kudo T; Hayashi T; Wakamura K; Sawada N; Ishida F; Miyachi H
Int J Colorectal Dis; 2020 Oct; 35(10):1911-1919. PubMed ID: 32548720
[TBL] [Abstract][Full Text] [Related]
38. [Colorectal cancer the importance of primary tumor location].
Ryska M; Bauer J
Rozhl Chir; 2017; 96(1):4-8. PubMed ID: 28325052
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials.
Tejpar S; Stintzing S; Ciardiello F; Tabernero J; Van Cutsem E; Beier F; Esser R; Lenz HJ; Heinemann V
JAMA Oncol; 2017 Feb; 3(2):194-201. PubMed ID: 27722750
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of primary tumor sidedness in patients with non-metastatic IBD related CRC - Is it the exception to the rule?
Kamphues C; Lefevre JH; Wang J; Amini N; Beaugerie L; Kuehn F; Park SH; Andreatos N; Lauscher JC; Enea D; Lehmann KS; Peru N; Weixler B; Kirchgesner J; Degro CE; Pozios I; van Beekum CJ; Schölch S; Zambonin D; Schineis C; Loch FN; Geka D; Theoxari M; Wu B; Wang PP; Antoniou E; Pikoulis E; Moussata D; Theodoropoulos G; Ouaissi M; Seeliger H; Inaba Y; Scaringi S; Reißfelder C; Vilz TO; Lin C; Yang SK; Beyer K; Renz BW; Sasaki K; Margonis GA; Svrcek M; Kreis ME
Surg Oncol; 2022 Dec; 45():101874. PubMed ID: 36257179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
